University of Houston: New Live Bacterial Product For Stubborn Superbug Improves Quality Of Life
February 01, 2023
February 01, 2023
HOUSTON, Texas, Feb. 1 (TNSjou) -- The University of Houston issued the following news release:
* * *
Microbiome Therapeutic Tackles C. Diff, the Most Common Health Care-Associated Infectious Agent in the U.S.
* * *
Kevin Garey, professor of pharmacy practice and translational research at the University of Houston College of Pharmacy is reporting the first well-controlled study to demonstrate that a microbiome therapeutic, SER-109, is associate . . .
* * *
Microbiome Therapeutic Tackles C. Diff, the Most Common Health Care-Associated Infectious Agent in the U.S.
* * *
Kevin Garey, professor of pharmacy practice and translational research at the University of Houston College of Pharmacy is reporting the first well-controlled study to demonstrate that a microbiome therapeutic, SER-109, is associate . . .